|
US20050272101A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
|
AU2005288522B2
(en)
*
|
2004-09-28 |
2012-06-28 |
Quark Pharmaceuticals, Inc. |
Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
|
|
PL1831699T3
(pl)
*
|
2004-12-20 |
2010-04-30 |
Antibodyshop As |
Oznaczanie lipokaliny neutrofilowej związanej z żelatynazą (NGAL) jako markera diagnostycznego dla zaburzeń nerek
|
|
WO2006078717A2
(en)
*
|
2005-01-19 |
2006-07-27 |
Beth Israel Deaconess Medical Center |
Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
|
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
|
US7825099B2
(en)
*
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
|
JP4865377B2
(ja)
|
2006-03-28 |
2012-02-01 |
国立大学法人 新潟大学 |
ヒトメガリンの測定方法
|
|
US7662578B2
(en)
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
|
US20080090765A1
(en)
*
|
2006-05-25 |
2008-04-17 |
The Trustees Of Columbia University In The City Of New York |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
|
|
WO2007137584A1
(en)
|
2006-05-30 |
2007-12-06 |
Antibodyshop A/S |
Methods and devices for rapid assessment of severity of injury
|
|
WO2008017306A1
(en)
*
|
2006-08-07 |
2008-02-14 |
Antibodyshop A/S |
Diagnostic test to exclude significant renal injury
|
|
WO2008060607A2
(en)
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
|
EP2095106B1
(en)
*
|
2006-11-14 |
2013-03-20 |
Alere San Diego, Inc. |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
|
JP5128828B2
(ja)
*
|
2007-02-16 |
2013-01-23 |
月桂冠株式会社 |
抗炎症剤及び抗酸化剤
|
|
EP2137538B1
(en)
|
2007-03-21 |
2014-04-09 |
Bioporto Diagnostics A/s |
Diagnostic test for renal injury
|
|
WO2009001359A2
(en)
*
|
2007-06-27 |
2008-12-31 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of pro-apoptotic genes
|
|
US8846036B2
(en)
|
2007-10-19 |
2014-09-30 |
Abbott Laboratories |
Antibodies that bind to mammalian NGAL and uses thereof
|
|
EP2257813A4
(en)
*
|
2008-03-12 |
2011-11-02 |
Univ Columbia |
NGAL WITH HIGH MOLECULAR WEIGHT AS BIOMARKER FOR CHRONIC KIDNEY DISEASE
|
|
US8030097B2
(en)
*
|
2008-04-30 |
2011-10-04 |
Versitech Limited and R & C Biogenius Limited |
Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
|
|
US8227439B2
(en)
|
2008-05-15 |
2012-07-24 |
Morphotek, Inc. |
Treatment of metastatic tumors
|
|
US20100122355A1
(en)
*
|
2008-07-16 |
2010-05-13 |
Neal Paragas |
Transgenic Reporter Mouse and Method for Use
|
|
EP2330897A4
(en)
*
|
2008-09-18 |
2013-11-27 |
Univ Columbia |
NGAL-BINDING SIDEROPHORES AND THEIR USE FOR THE TREATMENT OF IRON DEFICIENCY AND IRON SURPLUS
|
|
US20110212104A1
(en)
*
|
2008-11-03 |
2011-09-01 |
Schering Corporation |
Inflammatory bowel disease biomarkers and related methods of treatment
|
|
CN102292637B
(zh)
*
|
2008-11-21 |
2015-08-05 |
法蒂亚公司 |
用于检测或监测急性肾损伤的方法、装置和试剂盒
|
|
US20100233739A1
(en)
*
|
2009-02-12 |
2010-09-16 |
Jonathan Barasch |
Use of urinary ngal to diagnose unilateral and bilateral urinary obstruction
|
|
US20100233740A1
(en)
*
|
2009-02-12 |
2010-09-16 |
Jonathan Barasch |
Use of urinary ngal to distinguish kidney disease and predict mortality in subjects with cirrhosis
|
|
US8628930B2
(en)
|
2009-04-27 |
2014-01-14 |
Niigata University |
Use of megalin in urine as marker for detecting renal disorder
|
|
JP5424702B2
(ja)
|
2009-04-27 |
2014-02-26 |
国立大学法人 新潟大学 |
尿中ヒトメガリンを測定することを含む腎疾患検出方法
|
|
EP2292284B1
(en)
*
|
2009-09-04 |
2014-02-26 |
B. Braun Avitum AG |
Kidney substitution treatment machine
|
|
JP5858932B2
(ja)
|
2010-02-04 |
2016-02-10 |
モルフォテック， インコーポレイテッド |
クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
|
|
WO2011140554A1
(en)
*
|
2010-05-07 |
2011-11-10 |
The Trustees Of Columbia University In The City Of New York |
Ngal and urinary tract infection
|
|
JP2013532126A
(ja)
|
2010-05-11 |
2013-08-15 |
フレッド ハッチンソン キャンサー リサーチ センター |
クロロトキシン変異体、コンジュゲート、およびそれらを使用する方法
|
|
ES2667066T3
(es)
|
2010-05-24 |
2018-05-09 |
The Trustees Of Columbia University In The City Of New York |
Proteínas NGAL mutantes y usos de las mismas
|
|
ES2606140T3
(es)
*
|
2010-10-01 |
2017-03-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Métodos para predecir la progresión y tratar una enfermedad renal crónica en un paciente
|
|
EP2697389A4
(en)
*
|
2011-04-11 |
2014-09-10 |
Univ Columbia |
ABOUT OSTEOBLASTEN EXPRESSED LIPOCALIN 2 FOR THE ADJUSTMENT OF GLUCOSE COMPOUND CHANGES
|
|
WO2012167092A2
(en)
*
|
2011-06-03 |
2012-12-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Uses of and methods of treatment with cystathionine
|
|
EP2925337B1
(en)
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutant ngal proteins and uses thereof
|
|
CN105008393A
(zh)
|
2012-12-10 |
2015-10-28 |
弗莱德哈钦森癌症研究中心 |
用于筛选的方法
|
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
|
SI3200582T1
(sl)
|
2014-09-29 |
2024-04-30 |
Fred Hutchinson Cancer Center |
Sestave, kompleti in metode za indukcijo pridobljene citorezistence z uporabo induktorjev stresnih proteinov
|
|
JP5866053B1
(ja)
*
|
2014-12-15 |
2016-02-17 |
株式会社ファンケル |
皮膚粘弾性のマーカー及びその利用
|
|
WO2017027858A1
(en)
|
2015-08-12 |
2017-02-16 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating volume depletion and kidney injury
|
|
JP6909208B2
(ja)
|
2015-09-17 |
2021-07-28 |
アムジェン インコーポレイテッド |
Ｉｌ２３経路バイオマーカーを使用するｉｌ２３アンタゴニストに対する臨床応答の予測
|
|
EP3383415B1
(en)
|
2015-12-01 |
2021-03-31 |
Cornell University |
Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
|
|
AU2016379157A1
(en)
|
2015-12-22 |
2018-06-21 |
Amgen Inc. |
CCL20 as a predictor of clinical response to IL23-antagonists
|
|
TWI581802B
(zh)
|
2015-12-23 |
2017-05-11 |
國立臺灣師範大學 |
嗜中性白血球膠原蛋白質酶相關疏水性蛋白質之製藥用途
|
|
EP3184116B1
(en)
*
|
2015-12-23 |
2020-09-16 |
National Taiwan Normal University |
Neutrophil gelatinase-associated lipocalin for use in prevention or treatment of polycystic kidney disease
|
|
WO2017181149A1
(en)
|
2016-04-15 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
|
JP2020524714A
(ja)
*
|
2017-06-23 |
2020-08-20 |
エーケーアイ・セラピューティクス・エーぺーエス |
急性腎障害の予防及び治療のための組成物
|
|
US11298564B2
(en)
|
2020-03-10 |
2022-04-12 |
Dennis M. Anderson |
Medical, surgical and patient lighting apparatus, system, method and controls with pathogen killing electromagnetic radiation
|
|
CN113075371B
(zh)
*
|
2021-03-22 |
2022-11-18 |
重庆医药高等专科学校 |
一种药物崩解仪
|